EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases

Raghavender Reddy Gopireddy, Dipankar Bhattacharya, Swastik Sen, Monica A Schwartz, Scott L Friedman, Richard C Yu, Toshi Takeuchi, Lauren J Schwimmer

Molecular Pharmacology · 2026

DOI: 10.1016/j.molpha.2026.100102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2026. Verfasst von Raghavender Reddy Gopireddy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Abalone Bio, Inc., Emeryville, California. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB2, Macrophages, Inflammation, Liver Cirrhosis. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB2MacrophagesInflammationLiver CirrhosisAntibodiesHumansAnimalsMiceCytokines

Stichwörter der Autor:innen

Agonist antibodyCannabinoid receptorFibrosisGPCRInflammationMacrophage

Substanzen

Receptor, Cannabinoid, CB2AntibodiesCytokines

Autor:innen und Institutionen

  • Abalone Bio, Inc., Emeryville, California.
  • Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York.
  • Abalone Bio, Inc., Emeryville, California. Electronic address: lschwimmer@abalonebio.com.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NSF
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Small Business Innovation Research
  • National Institutes of Health National Cancer Institute
  • National Institutes of Health
  • National Science Foundation

Zitieren

APA

Gopireddy, R. R., Bhattacharya, D., Sen, S., Schwartz, M. A., Friedman, S. L., Yu, R. C., Takeuchi, T., & Schwimmer, L. J. (2026). Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2026.100102

Vancouver

Gopireddy RR, Bhattacharya D, Sen S, Schwartz MA, Friedman SL, Yu RC, et al. Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases. Molecular Pharmacology. 2026. doi:10.1016/j.molpha.2026.100102

BibTeX
@article{Gopireddy2026,
  author = {Gopireddy, Raghavender Reddy and Bhattacharya, Dipankar and Sen, Swastik and Schwartz, Monica A and Friedman, Scott L and Yu, Richard C and Takeuchi, Toshi and Schwimmer, Lauren J},
  title = {Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases},
  journal = {Molecular Pharmacology},
  year = {2026},
  doi = {10.1016/j.molpha.2026.100102}
}
Kostenlos starten →